Clinicopathological and therapeutic comparisons of esophageal cancer between China and the USA: a multicenter hospital-based study.

ABSTRACT:

Background

Esophageal cancer (EC) remains a global health challenge due to its poor prognosis. China and the United States of America (USA) represent two distinct epicenters of EC burden. Understanding the EC disparities in these two countries is vital for tailoring prevention strategies, optimizing treatment, and enhancing outcomes in both countries. Yet, there lacks a comprehensive comparison of EC characteristics between the two countries.

Methods

In this multicenter, retrospective hospital-based study, we enrolled primary EC patients who received their initial treatment at one of 23 hospitals in China during 2016-2017. Using electronic medical records and cancer registration records, information on demographics, lifestyle, and clinicopathological characteristics (includi

SUBMITTER: Zhu J 

PROVIDER: S-EPMC11674431 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature